| Year |
Citation |
Score |
| 2022 |
Quintino L, de Almeida LP, Lundberg C. Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches. Frontiers in Bioengineering and Biotechnology. 10: 1082883. PMID 36483777 DOI: 10.3389/fbioe.2022.1082883 |
0.547 |
|
| 2022 |
Martinsson I, Quintino L, Garcia MG, Konings SC, Torres-Garcia L, Svanbergsson A, Stange O, England R, Deierborg T, Li JY, Lundberg C, Gouras GK. Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer's Disease. Frontiers in Aging Neuroscience. 14: 946297. PMID 35928998 DOI: 10.3389/fnagi.2022.946297 |
0.509 |
|
| 2022 |
Quintino L, Gubinelli F, Sarauskyte L, Arvidsson E, Davidsson M, Lundberg C, Heuer A. Automated quantification of neuronal swellings in a preclinical rodent model of Parkinson's disease detects region-specific changes in pathology. Journal of Neuroscience Methods. 109640. PMID 35690332 DOI: 10.1016/j.jneumeth.2022.109640 |
0.548 |
|
| 2020 |
Di Maria V, Moindrot M, Ryde M, Bono A, Quintino L, Ledri M. Development and Validation of CRISPR Activator Systems for Overexpression of CB1 Receptors in Neurons. Frontiers in Molecular Neuroscience. 13: 168. PMID 33013319 DOI: 10.3389/fnmol.2020.00168 |
0.402 |
|
| 2020 |
Lockowandt M, Günther DM, Quintino L, Breger LS, Isaksson C, Lundberg C. Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector. Journal of Neuroscience Methods. 108542. PMID 32017975 DOI: 10.1016/J.Jneumeth.2019.108542 |
0.736 |
|
| 2018 |
Quintino L, Avallone M, Brännstrom E, Kavanagh P, Lockowandt M, Garcia Jareño P, Breger LS, Lundberg C. GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. Gene Therapy. PMID 30531868 DOI: 10.1038/S41434-018-0049-0 |
0.738 |
|
| 2018 |
Quintino L, Namislo A, Davidsson M, Breger LS, Kavanagh P, Avallone M, Elgstrand-Wettergren E, Isaksson C, Lundberg C. Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. Molecular Therapy. Methods & Clinical Development. 11: 29-39. PMID 30324128 DOI: 10.1016/J.Omtm.2018.08.008 |
0.789 |
|
| 2018 |
Fieblinger T, Zanetti L, Sebastianutto I, Breger LS, Quintino L, Lockowandt M, Lundberg C, Cenci MA. Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068. PMID 29968767 DOI: 10.1038/S41598-018-28273-5 |
0.72 |
|
| 2018 |
Davidsson M, Díaz-Fernández P, Torroba M, Schwich OD, Aldrin-Kirk P, Quintino L, Heuer A, Wang G, Lundberg C, Bjorklund T. Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing. Rna (New York, N.Y.). PMID 29386333 DOI: 10.1261/Rna.063925.117 |
0.553 |
|
| 2016 |
Breger L, Wettergren EE, Quintino L, Lundberg C. Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66. PMID 26611578 DOI: 10.1007/978-1-4939-3271-9_4 |
0.766 |
|
| 2015 |
Davidsson M, Aldrin-Kirk P, Díaz-Fernández P, Quintino L, Lundberg C, Björklund T. 345. A Novel Toolbox for RNA-Editing Based on Massively Parallel Screening Using Barcoded Viral Vectors Molecular Therapy. 23: S137-S138. DOI: 10.1016/S1525-0016(16)33954-5 |
0.472 |
|
| 2014 |
Wettergren EE, Quintino L, Lundberg C. Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats Journal of Gene Therapy Aspects. 1: 1. DOI: 10.7243/2057-164X-1-1 |
0.774 |
|
| 2014 |
Wettergren EE, Quintino L, Manfré G, Lundberg C. Gene therapy for Parkinson’s disease Neuromethods. 82: 181-191. DOI: 10.1007/978-1-62703-610-8_10 |
0.78 |
|
| 2013 |
Quintino L, Manfré G, Wettergren EE, Namislo A, Isaksson C, Lundberg C. Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 2169-80. PMID 23881415 DOI: 10.1038/Mt.2013.169 |
0.801 |
|
| 2013 |
Quintino L, Baudet A, Larsson J, Lundberg C. FACS binding assay for analysing GDNF interactions. Journal of Neuroscience Methods. 218: 25-8. PMID 23669067 DOI: 10.1016/j.jneumeth.2013.04.006 |
0.464 |
|
| 2013 |
Ã…kerblom M, Sachdeva R, Quintino L, Wettergren EE, Chapman KZ, Manfre G, Lindvall O, Lundberg C, Jakobsson J. Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9. Nature Communications. 4: 1770. PMID 23612311 DOI: 10.1038/Ncomms2801 |
0.756 |
|
| 2012 |
Lindgren N, Francardo V, Quintino L, Lundberg C, Cenci MA. A model of GDNF gene therapy in mice with 6-Hydroxydopamine lesions: time course of Neurorestorative effects and ERK1/2 activation. Journal of Parkinson's Disease. 2: 333-48. PMID 23938263 DOI: 10.3233/Jpd-012146 |
0.614 |
|
| 2012 |
Wettergren EE, Gussing F, Quintino L, Lundberg C. Novel disease-specific promoters for use in gene therapy for Parkinson's disease. Neuroscience Letters. 530: 29-34. PMID 23063686 DOI: 10.1016/J.Neulet.2012.09.059 |
0.75 |
|
| 2012 |
Tai K, Quintino L, Isaksson C, Gussing F, Lundberg C. Destabilizing domains mediate reversible transgene expression in the brain. Plos One. 7: e46269. PMID 23029456 DOI: 10.1371/Journal.Pone.0046269 |
0.776 |
|
| Show low-probability matches. |